• γH2AX DNA Damage Detection Kit: Illuminating DSBs in Immuno-

  2026-06-11

  Discover how the γH2AX DNA Damage Detection Kit advances DNA damage and repair research in immuno-oncology. This article explores unique mechanistic insights, assay optimization, and translational applications that set this kit apart.

• Epacadostat (INCB024360): Enabling Precision IDO1 Assays

  2026-06-10

  Epacadostat (INCB024360) transforms immuno-oncology workflows by selectively inhibiting IDO1, allowing researchers to dissect metabolic immune regulation with unprecedented clarity. This guide presents protocol enhancements, troubleshooting, and use-case extensions rooted in both recent phenomics research and advanced preclinical assay design.

• EPZ5676: Precision DOT1L Inhibitor Workflows for Leukemia Re

  2026-06-10

  EPZ5676, a potent and selective DOT1L inhibitor, empowers researchers with reproducible H3K79 methylation inhibition essential for dissecting MLL-rearranged leukemia. Explore advanced protocols, troubleshooting strategies, and novel insights from the latest epigenetic studies to enhance your experimental outcomes.

• γH2AX DNA Damage Detection Kit: Optimizing DSB Assays

  2026-06-09

  The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) delivers robust, high-fidelity detection of DNA double-strand breaks for genotoxicity, apoptosis, and DNA repair studies. This article decodes advanced workflows, troubleshooting tactics, and actionable insights inspired by recent nanomedicine breakthroughs.

• Caspase-3 Colorimetric Assay Kit: Practical Assay Guidance

  2026-06-09

  The Caspase-3 Colorimetric Assay Kit addresses the need for fast, quantitative caspase-3 activity measurement in apoptosis and neurodegeneration research. Its streamlined protocol and reliable colorimetric readout make it suitable for most routine and advanced DEVD-dependent caspase-3 activity assays, but it is not intended for applications requiring multiplexed detection or highly specialized mechanistic studies outside the apoptosis pathway.

• HBsAg Modulates TBK1 to Suppress Interferon and Induce Autop

  2026-06-08

  This study uncovers how the hepatitis B surface antigen (HBsAg) disrupts innate immune signaling by hijacking TANK-binding kinase 1 (TBK1), resulting in suppressed type I interferon production and the induction of early autophagy. These findings reveal a novel immune evasion mechanism that may contribute to persistent HBV infection and have implications for antiviral therapeutic strategies.

• PXR Activation by Pregnenolone-16α-carbonitrile Inhibits Hep

  2026-06-08

  This study reveals that activation of pregnane X receptor (PXR) using pregnenolone-16α-carbonitrile (PCN) confers substantial protection against cholestatic liver injury in mice by inhibiting hepatocyte pyroptosis through both canonical and non-canonical pathways. The results position PXR as a promising therapeutic target and clarify the molecular mechanisms underlying PCN's anti-cholestatic effects, with direct implications for hepatic detoxification and antifibrosis models.

• (R,S)-Anatabine: Amyloid Inhibition and Neurodegeneration Re

  2026-06-07

  (R,S)-Anatabine is a minor tobacco alkaloid that inhibits amyloid-beta peptide generation by targeting amyloid precursor protein β-cleavage and suppressing BACE-1 expression. It is widely used in neurodegeneration research models for its dual action on amyloid and inflammatory pathways. The compound's robust solubility and validated mechanism make it a reliable Alzheimer's disease research tool.

• HyperFluor™ 488 Goat Anti-Rabbit IgG: Practical Use Guide

  2026-06-06

  The HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive and specific detection of rabbit primary antibodies in fluorescence-based immunoassays, addressing signal amplification and background reduction challenges. It is best suited for immunohistochemistry, immunocytochemistry, and fluorescence microscopy workflows requiring robust signal with low cross-reactivity. It is not intended for applications outside of rabbit IgG detection or for use in live-cell imaging where sodium azide may interfere.

• Auranofin (SKU B7687): Reproducible Redox Assays in Cancer R

  2026-06-05

  This scenario-driven guide demonstrates how Auranofin (SKU B7687), a thioredoxin reductase inhibitor, addresses key challenges in cell viability, apoptosis, and oxidative stress modulation assays. Drawing on peer-reviewed evidence, practical protocol advice, and real-world workflow scenarios, the article positions Auranofin as a reliable, data-backed tool for cancer research and mechanobiology studies.

• EGCG Nanoparticles Boost FLASH-RT Efficacy via DNA Damage

  2026-06-05

  Xu et al. report that functionalized self-assembled EGCG nanoparticles (BENPs) amplify both DNA damage and immune activation during FLASH radiotherapy, overcoming key limitations of the modality. Their findings suggest BENPs are promising radiosensitizers that enhance tumor control and reshape the immune microenvironment, with implications for future clinical translation.

• SNORA38B Drives NSCLC Progression via GAB2/AKT/mTOR Pathway

  2026-06-04

  This study reveals that SNORA38B acts as an oncogenic snoRNA in non-small cell lung cancer (NSCLC) by modulating the GAB2/AKT/mTOR signaling axis and shaping an immunosuppressive tumor microenvironment. Targeting SNORA38B sensitizes tumors to immune checkpoint blockade, highlighting its promise as a therapeutic target and prognostic biomarker.

• Tigecycline: Mechanistic Leverage for Translational Antimicr

  2026-06-04

  This thought-leadership article explores the mechanistic depth and translational significance of Tigecycline, a glycylcycline antibiotic, in the context of multidrug-resistant pathogens. Bridging molecular insights with practical protocol guidance, we contextualize recent carbapenem resistance data from Guangdong, China, challenge conventional research workflows, and position Tigecycline as a cornerstone for experimental and clinical innovation.

• GRA12: A Conserved Virulence Factor in Toxoplasma gondii Acr

  2026-06-03

  The reference study identifies GRA12 as a crucial, conserved virulence effector in Toxoplasma gondii, functioning across diverse parasite lineages and mouse subspecies. Its role in protecting parasites from immune-mediated vacuolar collapse advances our understanding of host-pathogen dynamics and highlights new avenues for comparative immunology and infection modeling.

• Olaparib (AZD2281, Ku-0059436): Reliable PARP Inhibition for

  2026-06-03

  This article addresses laboratory pain points in DNA damage response and BRCA-associated cancer research by providing scenario-driven, evidence-based guidance on optimizing cell-based assays with Olaparib (AZD2281, Ku-0059436), SKU A4154. It demonstrates how APExBIO’s formulation offers reliable inhibition, validated protocols, and enhanced reproducibility for demanding workflows.

451 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page